Metastatic Tumor Doubling Time: Most Important Prehepatectomy Predictor of Survival and Nonrecurrence of Hepatic Colorectal Cancer Metastasis

World Journal of Surgery

Volumn 28, Issue 3, 2004, Pages 263-270

  Tanaka, Kuniya ^a   Shimada, Hiroshi ^a   Miura, Masaru ^a   Fujii, Yoshiro ^a   Yamaguchi, Shigeki ^a   Endo, Itaru ^a   Sekido, Hitoshi ^a   Togo, Shinji ^a   Ike, Hideyuki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PROTEIN P53;

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNE STATUS; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 1642290173     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7088-3     Document Type: Article

References (43)

1. Iwatsuki S, Esquivel CO, Gordon RD, et al. Liver resection for metastatic colorectal cancer. Surgery 1986;100:804-809
2. Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indication for resection. Surgery 1988;103:278-288
3. Scheele J, Stangl R, Altendorf-Hoffmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br. J. Surg. 1990;77:1241-1246
4. Bozzetti F, Doci R, Bignami P, et al. Patterns of failure following surgical resection of colorectal cancer liver metastases: rationale for multimodal approach. Ann. Surg. 1987;205:264-270
5. Ekberg H, Tranberg KG, Andersson R, et al. Determinants of survival in liver resection for colorectal secondaries. Br. J. Surg. 1986;73:727-731
6. Nordlinger B, Quilichini MA, Parc R, et al. Hepatic resection for colorectal liver metastases: influence on survival of preoperative factors and surgery for recurrence in 80 patients. Ann. Surg. 1987;205:256-263
7. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986;100:278-284
8. Fortner JG. Recurrence of colorectal cancer after hepatic resection. Am. J. Surg. 1988;155:378-382
9. Gayowski TJ, Iwatsuki S, Madariage JR, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994;116:703-711
10. Ekberg H, Tranberg KG, Andersson R, et al. Pattern of recurrence in liver resection for colorectal secondaries. World J. Surg. 1987;11:541-547
11. Doci R, Gennari L, Bignami P, et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br. J. Surg. 1991;78:797-801
12. Bozzetti F, Bignami P, Montalto F, et al. Repeat hepatic resection for recurrent metastases from colorectal cancer. Br. J. Surg. 1992;79:146-148
13. Hohenberger P, Schlag P, Schwarz V, et al. Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J. Surg. Oncol. 1990;44:245-251
14. Nordlinger B, Vaillant JC, Guignuet M, et al. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases: Association Françoise de Chirurgie. J. Clin. Oncol. 1994;12:1491-1496
15. Fong Y, Blumgart LH, Cohen A, et al. Repeat hepatic resections for metastatic colorectal cancer. Ann. Surg. 1994;220:657-662
16. Adam R, Bismuth H, Castaing D, et al. Repeat hepatectomy for colorectal liver metastases. Ann. Surg. 1997;225:51-62
17. Yamamoto J, Kosuge T, Shimada K, et al. Repeat liver resection for recurrent colorectal liver metastases. Am. J. Surg. 1999;178:275-281
18. Suzuki S, Sakaguchi T, Yokoi Y, et al. Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery 2001;129:421-428
19. Collins VP, Loeffler RK, Tivey H. Observation on growth rates of human tumors. AJR. Am. J. Roentgenol. 1956;76:988-1000
20. Koga H, Moriya Y, Akasu T, et al. The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas. Eur. J. Surg. Oncol. 1999;25:292-296
21. Umehara Y, Kimura T, Yoshida M, et al. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastasis lesions in recurrent gastric and colorectal carcinoma. Cancer 1993;71:4055-4059
22. Yamanaka N, Okamoto E, Kuwata K, et al. A multiple regression equation for prediction of posthepatectomy liver failure. Ann. Surg. 1984;200:658-663
23. Yasui K, Hirai T, Kato T, et al. A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann. Surg. 1997;226:582-586
24. Staab HJ, Andre FA, Hornung A, et al. Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancer. Br. J. Cancer 1982;46:773-781
25. Havelaar IJ, Sugerbaker PH, Vermes M, et al. Rate of growth of intraabdominal metastases from colorectal cancer. Cancer 1984;54:163-171
26. Shimada H, Nanko M, Fujii S, et al. Treatment strategies for hepatic metastasis from colorectal cancer. HPB Surg. 1995;2:116-121
27. Fujii S. Hepatic metastases development from colorectal cancer in view of CEA doubling time. Yokohama 1994;45:627-635
28. Hu YX, Watanabe H, Ohtsubo K, et al. Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. Clin. Cancer Res. 1997;3:1473-1477
29. Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nippon Geka Gakkai Zasshi. 1984;85:1001-1005
30. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 1999;230:309-318
31. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J. Surg. 1995;19:59-71
32. Harmon KE, Ryan JA, Biehl TR, et al. Benefits and safety of hepatic resection for colorectal metastases. Am. J. Surg. 1999;177:402-404
33. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Ann. Surg. 2000;231:487-499
34. Okano K, Yamamoto J, Kosuge T, et al. Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma: clinicopathologic study of 152 first resection cases. Cancer 2000;89:267-275
35. Weber JC, Nakano H, Bachellier P, et al. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am. J. Surg. 2001;182:81-88
36. Koike M, Yasui K, Torii A, et al. Prognostic significance of entrapped liver cells in hepatic metastases from colorectal cancer. Ann. Surg. 2000;232:653-657
37. Nitti D, Belluco C, Montesco MC, et al. Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival. Eur. J. Cancer 1998;34:851-855
38. Yamada H, Kondo S, Okushiba S, et al. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J. Surg. 2001;25:1129-1133
39. Ohta M, Ichikawa Y, Shimada H, et al. p53 and p21/waf1 expression are useful chemosensitivity markers of hepatic arterial infusion chemotherapy of residual: is relationship between p53 and p21/waf1 expression a chemosensitivity marker of residual liver recurrence after resection of liver metastasis from colorectal cancer? Hepatogastroenterology. in press
40. Stone MD, Cady B, Jenkins RL, et al. Surgical therapy for recurrent liver metastases from colorectal cancer. Arch. Surg. 1990;125:718-722
41. Yamamoto J, Sugihara K, Kosuge T, et al. Pathological support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann. Surg. 1995;221:74-78
42. Watine J, Miedouge M, Friedberg B. Carcinoembryonic antigen as an independent prognostic factor of recurrence and survival in patients resected for colorectal liver metastases: a systematic review. Dis. Colon Rectum 2001;44:1791-1799
43. Goseki N, Okamato A, Onodera T. Postoperative nutritional assessment in gastric and colorectal cancer. Nippon Geka Gakkai Zasshi. 1986;87:853-858